CD27 (Human) Activator/Inhibitor Screening Assay, Jurkat (CD27 & NFAT-Luc)-based (CAT#: ITS-1122-LX207)

Jurkat

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NF-kB response elements with constitutive expression of human CD27 (also known as Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, and T14, Genbank Accession #BC012160) Which can be used in binding assays and functional assay.

Jurkat (CD27 & NFAT-Luc)

Cancer

Oncology

In Vitro Activator/Inhibitor Screening Assay

Screen for agonists or antagonists of CD27-CD70 signaling in a physiologically relevant cellular context.

Creative Biolabs has developed several I-O function assay based on our stable cell Lines expressed the most popular immune checkpoints. CD27 (Human) Activator/Inhibitor Screening Assay, Jurkat (CD27 & NFAT-Luc)-based is applied to screen for agonists or antagonists of CD27-CD70 signaling in a physiologically relevant cellular context. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

In Vitro Activator/Inhibitor Screening Assay; Activator/Inhibitor Screening Assay

NFAT-Luciferase Reporter

Activator/Inhibitor Screening Assay

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NF-kB response elements with constitutive expression of human CD27 (also known as Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, and T14, Genbank Accession #BC012160) Which can be used in binding assays and functional assay.